Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

23 trials with published results (24%)

Research Maturity

62 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.2%

6 terminated out of 97 trials

Success Rate

91.2%

+4.6% vs benchmark

Late-Stage Pipeline

34%

33 trials in Phase 3/4

Results Transparency

37%

23 of 62 completed with results

Key Signals

23 with results91% success

Data Visualizations

Phase Distribution

84Total
Not Applicable (27)
Early P 1 (2)
P 1 (11)
P 2 (11)
P 3 (16)
P 4 (17)

Trial Status

Completed62
Recruiting8
Terminated6
Unknown6
Active Not Recruiting5
Withdrawn4

Trial Success Rate

91.2%

Benchmark: 86.5%

Based on 62 completed trials

Clinical Trials (97)

Showing 20 of 20 trials
NCT06507644Not ApplicableCompletedPrimary

Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses Treatment

NCT03906253Not ApplicableRecruitingPrimary

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

NCT06428721Not ApplicableRecruitingPrimary

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

NCT05662202Phase 3CompletedPrimary

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

NCT06461442Phase 4Enrolling By InvitationPrimary

Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

NCT03066843Not ApplicableCompletedPrimary

Photodynamic Therapy Incubation Times for Actinic Keratosis

NCT04429308Phase 2Not Yet RecruitingPrimary

PDT vs Peels for Treatment of Actinic Keratoses

NCT07273656Phase 3Not Yet Recruiting

Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead

NCT07401277Phase 1RecruitingPrimary

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

NCT07428941Completed

Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.

NCT05923060Phase 2CompletedPrimary

Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses

NCT07053852Phase 1CompletedPrimary

Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage

NCT07049068Phase 1CompletedPrimary

Comparison of Nicotinamide Treatments for Actinic Keratosis

NCT02373371Phase 3CompletedPrimary

Actinic Keratoses Treatment With Metvix® in Combination With Light

NCT06385340Not ApplicableRecruitingPrimary

Investigation of the Effect of Lipikar Baume AP+M

NCT06321003Recruiting

SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography

NCT06499415Phase 4RecruitingPrimary

Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

NCT04642287Phase 2Withdrawn

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

NCT04329221Phase 2Withdrawn

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

NCT06014697Completed

OCT and Invasion in Cutaneous Skin Lesions

Scroll to load more

Research Network

Activity Timeline